Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Barkun

Showing results (181-190 of 184) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 184 results.
Lancet (London, England)|January 14, 2024
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trialB Joseph Elmunzer, Lydia D Foster, Jose Serrano, et al.
Gastrointestinal Endoscopy|February 6, 2025
Thirty-day hospital admission following high-risk outpatient ERCP: incidence and analysis of risk factors based on a secondary analysis of the Stent Versus Indomethacin trial data setPatrick Yachimski, Jingwen Zhang, Gregory A Coté, et al.
The American Journal of Gastroenterology|August 29, 2024
Technical Factors Associated With the Benefit of Prophylactic Pancreatic Stent Placement During High-Risk Endoscopic Retrograde Cholangiopancreatography: A Secondary Analysis of the SVI Trial Data SetB Joseph Elmunzer, Jingwen Zhang, Gregory A Coté, et al.
Gastrointestinal Endoscopy|October 10, 2024
Impact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial datasetSamuel Han, Jingwen Zhang, Valerie Durkalski-Mauldin, et al.
Pageof 19

Showing results (181-190 of 184) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 184 results.
Lancet (London, England)|January 14, 2024
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trialB Joseph Elmunzer, Lydia D Foster, Jose Serrano, et al.
Gastrointestinal Endoscopy|February 6, 2025
Thirty-day hospital admission following high-risk outpatient ERCP: incidence and analysis of risk factors based on a secondary analysis of the Stent Versus Indomethacin trial data setPatrick Yachimski, Jingwen Zhang, Gregory A Coté, et al.
The American Journal of Gastroenterology|August 29, 2024
Technical Factors Associated With the Benefit of Prophylactic Pancreatic Stent Placement During High-Risk Endoscopic Retrograde Cholangiopancreatography: A Secondary Analysis of the SVI Trial Data SetB Joseph Elmunzer, Jingwen Zhang, Gregory A Coté, et al.
Gastrointestinal Endoscopy|October 10, 2024
Impact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial datasetSamuel Han, Jingwen Zhang, Valerie Durkalski-Mauldin, et al.
Pageof 19